| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.18 |
4e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0003 |
| mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0006 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.19 |
0.0006 |
| mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0006 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |